Also, when wt p53-containing cancer cells were challenged with p53-activating drugs, ectopic p53LCs drastically mitigated the wt p53-dependent toxic effects of these drugs (Figures 2 and 5; Supplementary Figure S3). This evidence concerns the gene TP53 and cancer.